drugset / Trial / NCT01515826
VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare VIGADEXA (moxifloxacin 0.5%/dexamethasone phosphate 0.075%) ophthalmic gel to VIGADEXA (moxifloxacin 0.5%/dexamethasone phosphate 0.1%) ophthalmic solution in the prevention of postoperative inflammation and infection.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 0.075 % | Topical |
| Comparator | Dexamethasone | Small molecule | 0.1 % | Topical |
| Comparator | Moxifloxacin | Small molecule | 0.5 % | Topical |